Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115485) titled 'A Study on the Efficacy of PD-1 Inhibitor Combined with Rosuvastatin as Maintenance Therapy in Patients with Diffuse Large B-Cell Lymphoma Following Autologous Stem Cell Transplantation' on Dec. 26, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine
Condition:
Diffuse large B-cell lymphoma
Recruitment Status: Recruiting
Phase: 2
Date of First Enrollment: 2023-05-15
Target Sample Size: Experimental arm:48;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showpr...